# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-015434
Filing Date
2025-04-24
Accepted
2025-04-24 16:07:28
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20045110x2_defa14a.htm | DEFA14A | 7584
2 |  | image0.jpg | GRAPHIC | 45859
3 |  | ny20045110x2_nc01.jpg | GRAPHIC | 421358
4 |  | ny20045110x2_nc02.jpg | GRAPHIC | 240508
| Complete submission text file | 0001140361-25-015434.txt |  | 983691

Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39580 | Film No.: 25867337
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)